Anergix $244,479
AVI Biopharma $1,222,395
Blood Cell Storage $488,958
Calistoga Pharmaceuticals $733,437
Calypso Medical Technologies $488,958
Cancer Targeted Technology $183,928
Cell Therapeutics $977,916
Cerevast Therapeutics $244,479
CG Therapeutics $244,479
CoCrystal Discovery $733,435
Columbia Northwest Pharmaceuticals $488,958
Ekos $297,683
Emergent Detection $229,900
Enject $244,479
Epigenomics $244,479
Etubics $244,479
Focused Scientific $23,232
Healionics $244,479
HemaQuest Pharmaceuticals $977,916
Hyprotek $244,479
Immune Design $488,958
Impel Neuropharma $244,479
Implicit Bioscience $244,479
Inimex Pharmaceuticals $244,479
Insilicos $244,479
Integrated Diagnostics $733,435
Pages: Page 1, Page 2, Page 3, Page 4
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
